Product Images Bicalutamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Bicalutamide NDC 47335-485 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bicalutamide-figure-1 - bicalutamide figure 1

bicalutamide-figure-1 - bicalutamide figure 1

The text describes a figure labeled "Figure 1" that shows the probability of death for two groups receiving different antiandrogen treatments. The figure is a graph with a line graph showing the Kaplan-Meier probability of death on the y-axis and the time since trial start on the x-axis. The two groups being compared are identified as "Bicalutamide plus LHRH-A" and "Flutamide plus LHRH-A". The proportion of individuals surviving is also shown on the y-axis. The time since the start of the trial is measured in days and ranges from 0 to 1825.*

bicalutamide-figure-2 - bicalutamide figure 2

bicalutamide-figure-2 - bicalutamide figure 2

The text describes a figure labeled "Figure 2" that consists of a Kaplan-Meier curve representing the time to progression for two antiandrogen treatment groups. The proportion not progressing is shown on the y-axis ranging from 0.3 to 1.0, while the x-axis represents the days to progression ranging from 0 to 1825. The two antiandrogen treatments compared are bicalutamide plus LHRH-A and flutamide plus LHRH-A.*

bicalutamide-structure - bicalutamide structure

bicalutamide-structure - bicalutamide structure

Not available.*

spl Bicalutamide Tablets

spl Bicalutamide Tablets

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.